| Insider | Mutz Christopher |
|---|---|
| Title | HEAD OF RARE DISEASE |
| Transaction Date | Feb 26, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 2, 2026 |
| Shares Purchased | 21,306 |
| Price per Share | $77.15 |
| Total Value | $1,643,757.90 |
| Shares Owned After | 106,146 |
| Derivative | No |
| Accession Number | 0001846487-26-000008 |
| Document | View SEC Filing |